Day Range1.700 - 1.925 | 52 Wk Range1.000 - 4.250 | Open / Close1.900 / - | Float / Outstanding3.094M / 3.106M |
Vol / Avg.1.194M / 2.503M | Mkt Cap5.467M | P/E- | 50d Avg. Price1.450 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float3.094M | EPS-1.990 |
Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
Day Range1.700 - 1.925 | 52 Wk Range1.000 - 4.250 | Open / Close1.900 / - | Float / Outstanding3.094M / 3.106M |
Vol / Avg.1.194M / 2.503M | Mkt Cap5.467M | P/E- | 50d Avg. Price1.450 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float3.094M | EPS-1.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-14 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 3.331M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Benchmark on Friday, July 20, 2018. The analyst firm set a price target for 3.00 expecting SNOA to rise to within 12 months (a possible 70.45% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $1.76 last updated Today at January 31, 2023 at 5:54 PM UTC.
There are no upcoming dividends for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, February 14, 2023.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
Day Range1.700 - 1.925 | 52 Wk Range1.000 - 4.250 | Open / Close1.900 / - | Float / Outstanding3.094M / 3.106M |
Vol / Avg.1.194M / 2.503M | Mkt Cap5.467M | P/E- | 50d Avg. Price1.450 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float3.094M | EPS-1.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-14 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 3.331M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Benchmark on Friday, July 20, 2018. The analyst firm set a price target for 3.00 expecting SNOA to rise to within 12 months (a possible 70.45% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $1.76 last updated Today at January 31, 2023 at 5:54 PM UTC.
There are no upcoming dividends for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, February 14, 2023.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
Day Range1.700 - 1.925 | 52 Wk Range1.000 - 4.250 | Open / Close1.900 / - | Float / Outstanding3.094M / 3.106M |
Vol / Avg.1.194M / 2.503M | Mkt Cap5.467M | P/E- | 50d Avg. Price1.450 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float3.094M | EPS-1.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-14 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 3.331M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Benchmark on Friday, July 20, 2018. The analyst firm set a price target for 3.00 expecting SNOA to rise to within 12 months (a possible 70.45% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $1.76 last updated Today at January 31, 2023 at 5:54 PM UTC.
There are no upcoming dividends for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, February 14, 2023.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
Day Range1.700 - 1.925 | 52 Wk Range1.000 - 4.250 | Open / Close1.900 / - | Float / Outstanding3.094M / 3.106M |
Vol / Avg.1.194M / 2.503M | Mkt Cap5.467M | P/E- | 50d Avg. Price1.450 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float3.094M | EPS-1.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-14 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 3.331M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Benchmark on Friday, July 20, 2018. The analyst firm set a price target for 3.00 expecting SNOA to rise to within 12 months (a possible 70.45% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $1.76 last updated Today at January 31, 2023 at 5:54 PM UTC.
There are no upcoming dividends for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, February 14, 2023.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
Day Range1.700 - 1.925 | 52 Wk Range1.000 - 4.250 | Open / Close1.900 / - | Float / Outstanding3.094M / 3.106M |
Vol / Avg.1.194M / 2.503M | Mkt Cap5.467M | P/E- | 50d Avg. Price1.450 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float3.094M | EPS-1.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-14 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 3.331M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Benchmark on Friday, July 20, 2018. The analyst firm set a price target for 3.00 expecting SNOA to rise to within 12 months (a possible 70.45% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $1.76 last updated Today at January 31, 2023 at 5:54 PM UTC.
There are no upcoming dividends for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, February 14, 2023.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
Day Range1.700 - 1.925 | 52 Wk Range1.000 - 4.250 | Open / Close1.900 / - | Float / Outstanding3.094M / 3.106M |
Vol / Avg.1.194M / 2.503M | Mkt Cap5.467M | P/E- | 50d Avg. Price1.450 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float3.094M | EPS-1.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-14 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 3.331M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Benchmark on Friday, July 20, 2018. The analyst firm set a price target for 3.00 expecting SNOA to rise to within 12 months (a possible 70.45% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $1.76 last updated Today at January 31, 2023 at 5:54 PM UTC.
There are no upcoming dividends for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, February 14, 2023.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
Day Range1.700 - 1.925 | 52 Wk Range1.000 - 4.250 | Open / Close1.900 / - | Float / Outstanding3.094M / 3.106M |
Vol / Avg.1.194M / 2.503M | Mkt Cap5.467M | P/E- | 50d Avg. Price1.450 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float3.094M | EPS-1.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-14 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 3.331M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Benchmark on Friday, July 20, 2018. The analyst firm set a price target for 3.00 expecting SNOA to rise to within 12 months (a possible 70.45% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $1.76 last updated Today at January 31, 2023 at 5:54 PM UTC.
There are no upcoming dividends for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, February 14, 2023.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
Day Range1.700 - 1.925 | 52 Wk Range1.000 - 4.250 | Open / Close1.900 / - | Float / Outstanding3.094M / 3.106M |
Vol / Avg.1.194M / 2.503M | Mkt Cap5.467M | P/E- | 50d Avg. Price1.450 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float3.094M | EPS-1.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-14 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 3.331M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Benchmark on Friday, July 20, 2018. The analyst firm set a price target for 3.00 expecting SNOA to rise to within 12 months (a possible 70.45% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $1.76 last updated Today at January 31, 2023 at 5:54 PM UTC.
There are no upcoming dividends for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, February 14, 2023.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
Day Range1.700 - 1.925 | 52 Wk Range1.000 - 4.250 | Open / Close1.900 / - | Float / Outstanding3.094M / 3.106M |
Vol / Avg.1.194M / 2.503M | Mkt Cap5.467M | P/E- | 50d Avg. Price1.450 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float3.094M | EPS-1.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-14 | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 3.331M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Benchmark on Friday, July 20, 2018. The analyst firm set a price target for 3.00 expecting SNOA to rise to within 12 months (a possible 70.45% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $1.76 last updated Today at January 31, 2023 at 5:54 PM UTC.
There are no upcoming dividends for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, February 14, 2023.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.